Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
We conclude that the therapeutic efficacy level of DHAP has remained high (>90%) since the baseline study in 2020/2021. Also, the baseline efficacy level of AP is high (>90%) warranting the use of both DHAP and AP in the treatment of uncomplicated malaria in the country.
Authors
- Kwadwo Koram (ORCID: https://orcid.org/0000-0003-4274-6516)
- Felicia Owusu-Antwi
- Nancy Odurowah Duah-Quashie (ORCID: https://orcid.org/0000-0001-8819-1793)
- Keziah Lawrencia Malm (ORCID: https://orcid.org/0000-0003-0190-0820)
- Sena Matrevi
- Neils B. Quashie (ORCID: https://orcid.org/0000-0002-2538-0324)
- Benjamin Abuaku (ORCID: https://orcid.org/0000-0002-1840-6979)
- Alexander Asamoah
- Eunice Obeng Amoako
- Paul Boateng
- Nana Yaw Peprah
Institutions
- World Health Organization - Pakistan (PK)
- Noguchi Memorial Institute for Medical Research (GH)
- Therapeutics Clinical Research (US)
- Ghana Health Service (GH)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fpubh.2025.1715777
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Global Fund to Fight AIDS, Tuberculosis and Malaria